D. Kirschmann

发表

A molecular role for lysyl oxidase in breast cancer invasion.

M. Hendrix, D. Kirschmann, E. Seftor, 2002, Cancer research.

Regulating the Tumor Suppressor Gene Maspin in Breast Cancer Cells

M. Hendrix, D. Kirschmann, Elijah M Edwards, 2004, Clinical Cancer Research.

Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

Olivier Delattre, Patrick Pauwels, Arjan W Griffioen, 2005, Cancer research.

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry

Paul S. Meltzer, Mary J. C. Hendrix, P. Meltzer, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Utilization of soluble fusion proteins for induction of T cell proliferation.

D. Kirschmann, S. Woulfe, M. Zacheis, 1995, Cellular immunology.

HETEROCHROMATIN-ASSOCIATED PROTEIN 1, IN BREAST CANCER INVASION AND METASTASIS

D. Kirschmann, 2002 .

New insights into cathepsin D in mammary tissue development and remodeling

M. Hendrix, D. Kirschmann, C. Bailey, 2010, Cancer biology & therapy.

Differences between young and aged mice in suceptibility to Friend virus

D. Kirschmann, K. Blank, D. Stewart, 1994, Mechanisms of Ageing and Development.

The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development.

M. Hendrix, D. Kirschmann, E. Seftor, 2002, Placenta.

Genetic Testing Requires NGS and Sanger Methodologies

D. Kirschmann, L. Jennings, 2016, Pediatric neurology briefs.

C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors.

M. Hendrix, D. Kirschmann, Z. Khalkhali‐Ellis, 1999, Journal of immunology.

Synoviocytes : Role of C 1 q Receptors Patients Mediate IL-8 Production by Human from Sera of Juvenile Rheumatoid Arthritis C 1 q-Containing Immune Complexes Purified

D. Kirschmann, Z. Khalkhali‐Ellis, T. Moore, 1999 .

Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.

D. Kirschmann, K. Duffin, S. Woulfe, 1995, Journal of immunology.

The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis.

D. Kirschmann, R. Slavin, C. Bellone, 1997, Journal of immunology.

Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

M. Hendrix, H. Boldt, L. M. Gardner, 1998, The American journal of pathology.

Targeting the Tumor Microenvironment with Chemically Modified Tetracyclines: Inhibition of Laminin 5 γ2 Chain Promigratory Fragments and Vasculogenic Mimicry1Supported by NIH/National Cancer Institute Grants CA83137 (to R. E. B. S.), CA80318, CA88043-02S1, and CA59702 (to M. J. C. H.).1

M. Hendrix, D. Kirschmann, E. Seftor, 2002 .

Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.

M. Hendrix, D. Kirschmann, E. Seftor, 2002, Molecular cancer therapeutics.

Phenotype Facilitates Manifestation of the Aggressive Melanoma Regulation of the Embryonic Morphogen Nodal by Notch4

M. Hendrix, D. Kirschmann, E. Seftor, 2010 .

The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing

D. Kirschmann, J. Dome, E. Perlman, 2018, Cancer.

Molecular Pathways: Vasculogenic Mimicry in Tumor Cells: Diagnostic and Therapeutic Implications

M. Hendrix, D. Kirschmann, E. Seftor, 2012, Clinical Cancer Research.

Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry.

P. Meltzer, M. Hendrix, D. Kirschmann, 2002, Critical reviews in oncology/hematology.

Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells

M. Hendrix, D. Kirschmann, E. Seftor, 2000, Breast Cancer Research.

Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells.

M. Hendrix, D. Kirschmann, E. Seftor, 2004, Journal of the National Cancer Institute.

Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells

M. Hendrix, V. Quaranta, D. Kirschmann, 2003, Annals of the New York Academy of Sciences.

Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype.

M. Hendrix, D. Kirschmann, E. Seftor, 2010, Cancer research.

The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment

P. Meltzer, M. Hendrix, D. Kirschmann, 2006, Journal of cellular and molecular medicine.

The Epigenetic Influence of the Tumor Microenvironment on Melanoma Plasticity

P. Meltzer, M. Hendrix, D. Kirschmann, 2005 .

Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401.

R. Karr, D. Kirschmann, T. Baudino, 1995, Arthritis and rheumatism.

Differentially expressed genes associated with the metastatic phenotype in breast cancer

M. Hendrix, D. Kirschmann, E. Seftor, 1999, Breast Cancer Research and Treatment.

A Requirement for Dimerization of HP1Hsα in Suppression of Breast Cancer Invasion*

M. Hendrix, D. Kirschmann, E. Seftor, 2006, Journal of Biological Chemistry.

Heterochromatin-Associated Protein 1, HP1Hsα, in Breast Cancer Invasion and Metastasis

M. Hendrix, D. Kirschmann, 2002 .

Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer.

M. Hendrix, L. M. Gardner, D. Kirschmann, 2000, Cancer research.

Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion

N. Colburn, D. Kirschmann, G. Hegamyer, 2010, Oncogene.

Molecular determinants of human uveal melanoma invasion and metastasis

P. Meltzer, M. Hendrix, J. Trent, 2004, Clinical & Experimental Metastasis.

Paradoxical roles for lysyl oxidases in cancer—A prospect

M. Hendrix, D. Kirschmann, S. L. Payne, 2007, Journal of cellular biochemistry.

Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.

D. Kirschmann, W. Schiemann, Molly A. Taylor, 2011, Neoplasia.

Hypoxia/reoxygenation: A dynamic regulator of lysyl oxidase‐facilitated breast cancer migration

M. Hendrix, D. Kirschmann, K. Csiszȧr, 2008, Journal of cellular biochemistry.

Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.

M. Hendrix, D. Kirschmann, E. Seftor, 2005, Cancer research.

Nodal signaling promotes a tumorigenic phenotype in human breast cancer.

M. Hendrix, D. Kirschmann, E. Seftor, 2014, Seminars in cancer biology.

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.

M. Hendrix, D. Kirschmann, E. Seftor, 2012, The American journal of pathology.

Development and cancer: at the crossroads of Nodal and Notch signaling.

M. Hendrix, D. Kirschmann, E. Seftor, 2009, Cancer research.

Does heterochromatin protein 1 always follow code?

D. Kirschmann, L. Wallrath, Lori L Wallrath, 2002, Proceedings of the National Academy of Sciences of the United States of America.

A peptidomimetic that specifically inhibits human leukocyte antigen DRB1*0401-restricted T cell proliferation.

D. Kirschmann, T. Baudino, S. Woulfe, 1997, The Journal of pharmacology and experimental therapeutics.

Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients.

J. Cerhan, T. Sellers, M. Hendrix, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

A case of aberrant CD8 T cell–restricted IL-7 signaling with a Janus kinase 3 defect–associated atypical severe combined immunodeficiency

R. Fuleihan, D. Kirschmann, B. Simpson, 2020, Immunologic Research.

A case of aberrant CD8 T cell–restricted IL-7 signaling with a Janus kinase 3 defect–associated atypical severe combined immunodeficiency

R. Fuleihan, D. Kirschmann, B. Simpson, 2020, Immunologic research.

Lysyl oxidase regulates actin filament formation through the p130Cas/Crk/DOCK180 signaling complex

M. Hendrix, D. Kirschmann, S. L. Payne, 2006, Journal of cellular biochemistry.

CD4 T cell-restricted IL-2 signaling defect in a patient with a novel IFNGR1 deficiency.

R. Fuleihan, D. Kirschmann, A. Khanolkar, 2018, The Journal of allergy and clinical immunology.

Transcript analysis for variant classification resolution in a child with primary ciliary dyskinesia

J. Charrow, D. Kirschmann, Sabah Kadri, 2021, Cold Spring Harbor molecular case studies.

Down-Regulation of HP1 Hs a Expression Is Associated with the Metastatic Phenotype in Breast Cancer 1

M. Hendrix, D. Kirschmann, E. Seftor, 2000 .

Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells

M. Hendrix, D. Kirschmann, E. Seftor, 2008, Proceedings of the National Academy of Sciences.

Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli.

D. Kirschmann, D. Murasko, 1992, Cellular immunology.

Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.

L. Chin, M. Hendrix, K. Brown, 2005, Cancer research.

Conserved properties of HP1Hsα

M. Hendrix, D. Kirschmann, L. Wallrath, 2004 .

Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment.

M. Hendrix, M. Soares, M. Bonaldo, 2009, Epigenomics.

A novel immunological model for the study of prostate cancer.

M. Hendrix, J. Luo, D. Kirschmann, 1999, Cancer research.

Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis.

M. Hendrix, D. Kirschmann, E. Seftor, 2000, The Journal of rheumatology.

Nodal expression and detection in cancer: experience and challenges.

M. Hendrix, D. Kirschmann, L. Strizzi, 2012, Cancer research.

Lessons from Embryogenesis

M. Hendrix, D. Kirschmann, E. Seftor, 2011 .

Effect of exogenous cytokines on the inhibition of macrophage-induced, antigen-specific T cell proliferation by poly(I:C).

D. Kirschmann, D. Murasko, 1992, Clinical immunology and immunopathology.

Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells

M. Hendrix, A. Hinck, D. Kirschmann, 2015, International journal of cancer.

Conserved properties of HP1(Hsalpha).

M. Hendrix, D. Kirschmann, L. Wallrath, 2004, Gene.

Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells

M. Hendrix, D. Kirschmann, E. Seftor, 2000, Breast Cancer Research.

Inhibition of macrophage-induced antigen-specific T lymphocyte proliferation by poly I:C: strain and antigen independence.

D. Kirschmann, D. Murasko, 1991, Cellular Immunology.

Molecular Pathways Molecular Pathways : Vasculogenic Mimicry in Tumor Cells : Diagnostic and Therapeutic Implications

M. Hendrix, D. Kirschmann, E. Seftor, 2012 .

Distinctive Clinicopathologic Features of Monomorphic B-cell Post-transplant Lymphoproliferative Disorders in Children

D. Kirschmann, K. Yap, Xinyan Lu, 2021, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.